Literature DB >> 23540091

HIV positivity in TB suspects--an observational, non-randomized study.

Parminder Kaur1, Poonam Sharma, Aruna Aggarwal.   

Abstract

AIMS: The present study was carried out to determine the prevalence of TB, HIV, and TB- HIV co-infection in 618 patients who attended the health institute for TB diagnosis and treatment at a rural tertiary care hospital in Punjab.
METHODS: Pulmonary T.B was diagnosed by sputum smear microscopy, culture and extra-pulmonary TB was diagnosed by X-ray, CT and other methods. HIV diagnosis was made by testing the sera by 3E/R/S (ELISA/RAPID/SIMPLE) tests as per NACO guidelines.
RESULTS: Of the total 618 patients, 74(12%) were patients of pulmonary TB, out of whom 72 were diagnosed by Ziehl Neelsen (ZN) staining and two were diagnosed by culture as the ZN stained smear was negative, 169(27.3%) were cases of extra-pulmonary TB. Three out of 618 were HIV positive. 1.23% were TB- HIV co-infected.
CONCLUSION: The risk of developing TB increases in patients with HIV. So, HIV and TB programmes should be collaborated together and should be closely integrated with medical care to curb the spread of these deadly diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23540091

Source DB:  PubMed          Journal:  Indian J Tuberc        ISSN: 0019-5707


  2 in total

1.  Provider-initiated HIV testing & counselling in incident tuberculosis cases under National TB Programme conditions at a tertiary care teaching hospital in Tirupati, south India.

Authors:  Alladi Mohan; J Harikrishna; D Prabath Kumar; N Dinesh Kumar; Prerna S Sharma; B Siddhartha Kumar; K V S Sarma
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

Review 2.  High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta-analyses.

Authors:  Marriott Nliwasa; Peter MacPherson; Ankur Gupta-Wright; Mphatso Mwapasa; Katherine Horton; Jon Ø Odland; Clare Flach; Elizabeth L Corbett
Journal:  J Int AIDS Soc       Date:  2018-07       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.